KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist: characterization using recombinant human alpha 1-adrenoceptors and native tissues
-
- Shibata
- Creator
Journal
-
- Mol. Pharmacol.
-
Mol. Pharmacol. 48 250-, 1995